Yuhan Corporation
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Yuhan Corporation
RECRUITINGPhase 1 / Phase 2NCT05523947
Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
This first-in-human study will be counducted to evaluate the safety, tolerability, pharmacokinetics (PK) and anti-tumor activity of YH32367 in Patients with HER2-Positive Locally...
Sponsor: Yuhan CorporationEnrolling: 14719 locations
HER2-Positive Solid Tumor
RECRUITINGPhase 1NCT06517914
A First-in-Human, Single- and Multiple-Ascending Dose Study of YH35995 in Healthy Adult Male Participants
This is a randomized, double-blind, first-in-human study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple oral doses of YH35995
Sponsor: Yuhan CorporationEnrolling: 861 location
Healthy Participants